Skip to main content

ADVERTISEMENT

quality of care

Research in Review
06/28/2017
JCP Editors
Positron emission tomography (PET) and computed tomography (CT) scans specific to prostate cancer can detect further disease and improve clinical management, according to recent research. Ga68-Prostate Specific...
Positron emission tomography (PET) and computed tomography (CT) scans specific to prostate cancer can detect further disease and improve clinical management, according to recent research. Ga68-Prostate Specific...
...
06/28/2017
Journal of Clinical Pathways
Research in Review
06/27/2017
JCP Editors
Clinical trial participation for patients with cancer often result in measurable benefits, including lowered costs and extended survival. ----- Related Content Trial Shows Precision Medicine Improves Cancer...
Clinical trial participation for patients with cancer often result in measurable benefits, including lowered costs and extended survival. ----- Related Content Trial Shows Precision Medicine Improves Cancer...
...
06/27/2017
Journal of Clinical Pathways
Research in Review
06/26/2017
JCP Editors
A routinely available blood test can help improve risk stratification and guide additional therapy for stage II colon cancer. ----- Related Content Adjuvant Chemotherapy Improves Colon Cancer Outcomes Colon...
A routinely available blood test can help improve risk stratification and guide additional therapy for stage II colon cancer. ----- Related Content Adjuvant Chemotherapy Improves Colon Cancer Outcomes Colon...
A...
06/26/2017
Journal of Clinical Pathways
Research in Review
06/26/2017
JCP Editors
A recent analysis reports a cost-effective alternative modality that demonstrates similar efficacy to traditional breast magnetic resonance imaging (MRI), published in the American Journal of Roentgenology (June...
A recent analysis reports a cost-effective alternative modality that demonstrates similar efficacy to traditional breast magnetic resonance imaging (MRI), published in the American Journal of Roentgenology (June...
A...
06/26/2017
Journal of Clinical Pathways
Research in Review
06/22/2017
JCP Editors
Standard induction chemotherapy is noninferior to high-dose chemotherapy in patients with newly diagnosed acute myeloid leukemia (AML), according to new research published in the Journal of Clinical Oncology...
Standard induction chemotherapy is noninferior to high-dose chemotherapy in patients with newly diagnosed acute myeloid leukemia (AML), according to new research published in the Journal of Clinical Oncology...
...
06/22/2017
Journal of Clinical Pathways
Research in Review
06/22/2017
JCP Editors
A recent study compared the effects of first-line chemotherapy with two different drugs in patients with advanced or metastatic colorectal cancer, published in JAMA (2017;317[23]:2392-2401). ----- Related...
A recent study compared the effects of first-line chemotherapy with two different drugs in patients with advanced or metastatic colorectal cancer, published in JAMA (2017;317[23]:2392-2401). ----- Related...
A...
06/22/2017
Journal of Clinical Pathways
Research in Review
06/20/2017
JCP Editors
Women with advanced ovarian cancer who express a certain tumor antigen will likely experience a shorter progression-free survival (PFS) and overall survival (OS) than those without the antigen, according to research...
Women with advanced ovarian cancer who express a certain tumor antigen will likely experience a shorter progression-free survival (PFS) and overall survival (OS) than those without the antigen, according to research...
Women...
06/20/2017
Journal of Clinical Pathways
Research in Review
06/20/2017
JCP Editors
A higher dose treatment for a type of metastatic gastric adenocarcinoma showed equivalent efficacy and safety, according to research published in the Journal of Clinical Oncology (published online June 2017;...
A higher dose treatment for a type of metastatic gastric adenocarcinoma showed equivalent efficacy and safety, according to research published in the Journal of Clinical Oncology (published online June 2017;...
A...
06/20/2017
Journal of Clinical Pathways
Research in Review
06/19/2017
JCP Editors
Older patients with chronic myelomonocytic leukemia (CMML) who are treated with hypomethylating agents reduce their risk of disease-related mortality by 28%, according to new research published in Cancer (published...
Older patients with chronic myelomonocytic leukemia (CMML) who are treated with hypomethylating agents reduce their risk of disease-related mortality by 28%, according to new research published in Cancer (published...
Older...
06/19/2017
Journal of Clinical Pathways
Research in Review
06/19/2017
JCP Editors
Researchers developed a method of identifying candidates with rheumatoid arthritis (RA) for dose reduction of disease modifying anti-rheumatic drugs (DMARDs). ----- Related Content Certolizumab combo helps curb RA...
Researchers developed a method of identifying candidates with rheumatoid arthritis (RA) for dose reduction of disease modifying anti-rheumatic drugs (DMARDs). ----- Related Content Certolizumab combo helps curb RA...
...
06/19/2017
Journal of Clinical Pathways